Skip to main content
. 2016 Dec 21;9:9–17. doi: 10.2147/CEOR.S108730

Figure 3.

Figure 3

Percentage of patients switching from initial therapy.

Notes: First year: Eta vs. Ada p=0.05; Eta vs. Inf p=0.25; Ada vs. Inf p=0.55. Second year: Eta vs. Ada p=0.18; Eta vs. Inf p=0.05; Ada vs. Inf p=0.64.

Abbreviations: Eta, etanercept; Ada, adalimumab; Inf, infliximab.